Quick Takeaways
- Lynx1 Capital Management LP filed SCHEDULE 13D/A for Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share (NEUP).
- Disclosed ownership: 26%.
- Date of event: 09 Nov 2025.
Lynx1 Capital Management LP - 09 Nov 2025 SCHEDULE 13D/A Report for Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share (NEUP)
- Filing Manager
- Lynx1 Capital Management LP
- Reporting Manager
- Lynx1 Capital Management LP
- Symbol
- NEUP
- Shares outstanding
- 3,303,125 shares
- Disclosed Ownership
- 875,328 shares
- Ownership
- 26%
- Form type
- SCHEDULE 13D/A
- Filing time
- 10 Nov 2025, 14:33:07 UTC
- Date of event
- 09 Nov 2025
- Previous filing
- 23 Oct 2025
- Next filing
- 18 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Lynx1 Capital Management LP disclosed 26% ownership in Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share (NEUP) on 09 Nov 2025."
What Changed
- Previous schedule filing date: 23 Oct 2025.
- Current filing was accepted on 10 Nov 2025, 14:33.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 26% | 875,328 | 0 | 875,328 | /s/ Weston Nichols | By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member | 0001910456 |
| Weston Nichols | 26% | 875,328 | 0 | 875,328 | /s/ Weston Nichols | Weston Nichols, individually |